Other Assets, Current of Y-mAbs Therapeutics, Inc. from 31 Dec 2017 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Y-mAbs Therapeutics, Inc. quarterly Other Assets, Current in USD history and change rate from 31 Dec 2017 to 30 Jun 2025.
  • Y-mAbs Therapeutics, Inc. Other Assets, Current for the quarter ending 30 Jun 2025 was $4,035,000, a 80% increase year-over-year.
Source SEC data
View on sec.gov
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Change (%)

Y-mAbs Therapeutics, Inc. Quarterly Other Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $4,035,000 +$1,792,000 +80% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $4,403,000 +$921,000 +26% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $4,373,000 -$582,000 -12% 31 Dec 2024 10-Q 08 Aug 2025 2025 Q2
Q3 2024 $1,462,000 -$840,000 -36% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $2,243,000 -$1,327,000 -37% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $3,482,000 -$248,000 -6.6% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $4,955,000 -$497,000 -9.1% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $2,302,000 -$923,000 -29% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $3,570,000 -$2,683,000 -43% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $3,730,000 -$2,373,000 -39% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $5,452,000 -$2,021,000 -27% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $3,225,000 +$426,000 +15% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $6,253,000 +$2,808,000 +82% 30 Jun 2022 10-Q 08 Aug 2022 2021 Q3
Q1 2022 $6,103,000 +$1,367,000 +29% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $7,473,000 -$256,000 -3.3% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $2,799,000 +$857,000 +44% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $3,445,000 -$1,816,000 -35% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $4,736,000 +$674,000 +17% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $7,729,000 +$2,910,000 +60% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $1,942,000 +$543,000 +39% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $5,261,000 +$2,234,000 +74% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $4,062,000 +$1,303,000 +47% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $4,819,000 +$1,158,000 +32% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $1,399,000 -$1,322,000 -49% 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $3,027,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $2,759,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $3,661,000 +$2,821,000 +336% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 $2,721,000 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q4 2017 $840,000 31 Dec 2017 10-K 22 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.